Pluvio J Coronado, Ana Gómez, Eva Iglesias, María Fasero, Laura Baquedano, Sonia Sánchez, Isabel Ramírez-Polo, Esther de la Viuda, Borja Otero, Plácido Llaneza, Nicolás Mendoza, Daniel M Lubián
IMPORTANCE: Menopause hormone therapy (MHT) effectively alleviates menopausal symptoms. However, it is generally not recommended for breast cancer survivors, although the scientific evidence is scarce. OBJECTIVE: This study aimed to establish eligibility criteria for use of the MHT in breast cancer survivors based on a systematic review and meta-analysis of the literature. EVIDENCE REVIEW: We conducted exhaustive literature searches until June 2022 in MEDLINE, The Cochrane Library, and EMBASE, using a tailored strategy with a combination of controlled vocabulary and search terms related to breast cancer survivors and MHT...
March 1, 2024: Menopause: the Journal of the North American Menopause Society